Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Schizophrenia

  Free Subscription


Articles published in Br J Psychiatry

Retrieve available abstracts of 32 articles:
HTML format



Single Articles


    July 2022
  1. FLEETWOOD K, Wild SH, Smith DJ, Mercer SW, et al
    Association of severe mental illness with stroke outcomes and process-of-care quality indicators: nationwide cohort study.
    Br J Psychiatry. 2022;221:394-401.
    PubMed     Abstract available


    May 2022
  2. CURTIS D
    Identification of specific genes involved in schizophrenia aetiology - what difference does it make? - CORRIGENDUM.
    Br J Psychiatry. 2022 May 23:1. doi: 10.1192/bjp.2022.
    PubMed    


    April 2022
  3. CURTIS D
    Identification of specific genes involved in schizophrenia aetiology - what difference does it make?
    Br J Psychiatry. 2022 Apr 6:1-3. doi: 10.1192/bjp.2021.
    PubMed     Abstract available


    February 2022
  4. ANTONUCCI LA, Penzel N, Sanfelici R, Pigoni A, et al
    Using combined environmental-clinical classification models to predict role functioning outcome in clinical high-risk states for psychosis and recent-onset depression.
    Br J Psychiatry. 2022 Feb 14:1-17. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


  5. CUI Y, Li C, Liu B, Sui J, et al
    Consistent brain structural abnormalities and multisite individualised classification of schizophrenia using deep neural networks.
    Br J Psychiatry. 2022 Feb 11:1-8. doi: 10.1192/bjp.2022.
    PubMed     Abstract available


    January 2022
  6. LEE R, Leighton SP, Thomas L, Gkoutos GV, et al
    Prediction models in first-episode psychosis: systematic review and critical appraisal.
    Br J Psychiatry. 2022 Jan 24:1-13. doi: 10.1192/bjp.2021.
    PubMed     Abstract available


    December 2021
  7. XI YB, Wu XS, Cui LB, Bai LJ, et al
    Neuroimaging-based brain-age prediction of first-episode schizophrenia and the alteration of brain age after early medication.
    Br J Psychiatry. 2021 Dec 2:1-8. doi: 10.1192/bjp.2021.
    PubMed     Abstract available


  8. BAKER SJ, Jackson M, Jongsma H, Saville CWN, et al
    The ethnic density effect in psychosis: a systematic review and multilevel meta-analysis.
    Br J Psychiatry. 2021;219:632-643.
    PubMed     Abstract available


  9. BHUI K, Halvorsrud K, Mooney R, Hosang GM, et al
    Is psychosis a syndemic manifestation of historical and contemporary adversity? Findings from UK Biobank.
    Br J Psychiatry. 2021;219:686-694.
    PubMed     Abstract available


  10. ELLETT L, Chadwick P
    Recommendations for monitoring and reporting harm in mindfulness for psychosis research.
    Br J Psychiatry. 2021;219:629-631.
    PubMed     Abstract available


    July 2021
  11. MCDONALD K, Ding T, Ker H, Dliwayo TR, et al
    Using epidemiological evidence to forecast population need for early treatment programmes in mental health: a generalisable Bayesian prediction methodology applied to and validated for first-episode psychosis in England.
    Br J Psychiatry. 2021;219:383-391.
    PubMed     Abstract available


  12. VAN DER MEER L, Kaiser S, Castelein S
    Negative symptoms in schizophrenia: reconsidering evidence and focus in clinical trials.
    Br J Psychiatry. 2021;219:359-360.
    PubMed     Abstract available


  13. CASTELEIN S, Timmerman ME, van der Gaag M, Visser E, et al
    Clinical, societal and personal recovery in schizophrenia spectrum disorders across time: states and annual transitions.
    Br J Psychiatry. 2021;219:401-408.
    PubMed     Abstract available


  14. ZHU Y, Wang S, Gong X, Edmiston EK, et al
    Associations between hemispheric asymmetry and schizophrenia-related risk genes in people with schizophrenia and people at a genetic high risk of schizophrenia.
    Br J Psychiatry. 2021;219:392-400.
    PubMed     Abstract available


  15. BHATTACHERJEE S, Young A, Ahuja N, Allen S, et al
    Should intramuscular clozapine be adopted into mainstream clinical practice?
    Br J Psychiatry. 2021;219:357-358.
    PubMed     Abstract available


    May 2021
  16. SISKIND D, Orr S, Sinha S, Yu O, et al
    Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis.
    Br J Psychiatry. 2021 May 11:1-6. doi: 10.1192/bjp.2021.
    PubMed     Abstract available


    January 2021
  17. CHAN JKN, Wong CSM, Or PCF, Chen EYH, et al
    Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study.
    Br J Psychiatry. 2021 Jan 7:1-8. doi: 10.1192/bjp.2020.
    PubMed     Abstract available


    December 2020
  18. JIN H, Tappenden P, MacCabe JH, Robinson S, et al
    Cost and health impacts of adherence to the National Institute for Health and Care Excellence schizophrenia guideline recommendations.
    Br J Psychiatry. 2020 Dec 14:1-6. doi: 10.1192/bjp.2020.
    PubMed     Abstract available


    November 2020
  19. BRENNAN D
    Sarcosine in the management of schizophrenia.
    Br J Psychiatry. 2020;217:653.
    PubMed    


  20. CURTIS D
    Author's reply.
    Br J Psychiatry. 2020;217:653.
    PubMed    


    October 2020
  21. HEINZE K, Barron HC, Howes EK, Ramaswami M, et al
    Impaired inhibitory processing: a new therapeutic target for autism and psychosis?
    Br J Psychiatry. 2020 Oct 23:1-4. doi: 10.1192/bjp.2020.
    PubMed     Abstract available


  22. BOGE K, Thomas N, Jacobsen P
    Is mindfulness for psychosis harmful? Deconstructing a myth.
    Br J Psychiatry. 2020 Oct 1:1-2. doi: 10.1192/bjp.2020.
    PubMed     Abstract available


  23. FOND G, Pauly V, Bege T, Orleans V, et al
    Trauma-related mortality of patients with severe psychiatric disorders: population-based study from the French national hospital database.
    Br J Psychiatry. 2020;217:568-574.
    PubMed     Abstract available


    September 2020
  24. LEMONDE AC, Joober R, Malla A, Iyer SN, et al
    Delusional content at initial presentation to a catchment-based early intervention service for psychosis.
    Br J Psychiatry. 2020 Sep 9:1-7. doi: 10.1192/bjp.2020.
    PubMed     Abstract available


    August 2020
  25. CROSSLEY NA, Zugman A, Reyes-Madrigal F, Czepielewski LS, et al
    Structural brain abnormalities in schizophrenia in adverse environments: examining the effect of poverty and violence in six Latin American cities.
    Br J Psychiatry. 2020 Aug 18:1-7. doi: 10.1192/bjp.2020.
    PubMed     Abstract available


  26. CASERAS X, Kirov G, Kendall KM, Rees E, et al
    Effects of genomic copy number variants penetrant for schizophrenia on cortical thickness and surface area in healthy individuals: analysis of the UK Biobank.
    Br J Psychiatry. 2020 Aug 14:1-8. doi: 10.1192/bjp.2020.
    PubMed     Abstract available


  27. SALUJA N, Khurana H
    Letter to the editor about 'Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis'.
    Br J Psychiatry. 2020;217:458.
    PubMed    


    July 2020
  28. MALLA A, Iyer SN, Rangaswamy T, Ramachandran P, et al
    Comparison of clinical outcomes following 2 years of treatment of first-episode psychosis in urban early intervention services in Canada and India.
    Br J Psychiatry. 2020 Jul 6:1-7. doi: 10.1192/bjp.2020.
    PubMed     Abstract available


  29. CASETTA C, Oloyede E, Whiskey E, Taylor DM, et al
    A retrospective study of intramuscular clozapine prescription for treatment initiation and maintenance in treatment-resistant psychosis.
    Br J Psychiatry. 2020 Jul 1:1-8. doi: 10.1192/bjp.2020.
    PubMed     Abstract available


    June 2020
  30. CHEN J, Chen R, Xiang S, Li N, et al
    Cigarette smoking and schizophrenia: Mendelian randomisation study.
    Br J Psychiatry. 2020 Jun 18:1-6. doi: 10.1192/bjp.2020.
    PubMed     Abstract available


    May 2020
  31. OHI K, Shimada T, Kataoka Y, Yasuyama T, et al
    Genetic correlations between subcortical brain volumes and psychiatric disorders.
    Br J Psychiatry. 2020;216:280-283.
    PubMed     Abstract available


    March 2020
  32. JANAWAY BM, Kripalani M
    Response letter to the article by Killackey et al (2019) 'Individual placement and support for vocational recovery in first-episode psychosis: randomised controlled trial'.
    Br J Psychiatry. 2020;216:167.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: